Flier
Holger-Frederik Robert Flier, Zurich CH
Patent application number | Description | Published |
---|---|---|
20150345973 | Detecting Important Transit Stops for Transit Trip Grouping - Systems and methods for identifying a direction name associated a transit trip along a transit line for use in, for instance, grouping departure times or arrival times associated with transit trips at a transit stop are provided. Data indicative or an ordering ranking the plurality of transit stops in terms of importance can be accessed. Important transit stops between the reference transit stop and an ending transit stop associated with a transit trip can be identified using the ordering of the plurality of transit stops. The station names associated with the identified important transit stops can be used as a basis for the direction name associated with the transit trip at the particular reference transit stop. Departure times can be grouped by the identified direction names and using other parameters, such as by headsign. | 12-03-2015 |
Jeffrey Flier, Newton, MA US
Patent application number | Description | Published |
---|---|---|
20100111940 | COMPOSITIONS CONTAINING ALPHA-1-ANTITRYPSIN AND METHODS FOR USE - Methods and compositions for treating patients (e.g., patients who are insulin resistant, patients who have diabetes, or are at risk for developing diabetes) are disclosed herein. The methods can include administration of an a1 antitrypsin (AAT) polypeptide or an agent, such as a nucleic acid molecule or organic compound, that promotes the expression or activity of a1-antitrypsin. | 05-06-2010 |
20110020269 | METHODS AND COMPOSITIONS FOR MODIFYING T CELL IMMUNE RESPONSES AND INFLAMMATION - Methods and compositions for immune modulation are described herein. The compositions encompass pharmaceutical compositions that include a combination of agents. The first agent can selectively stimulate regulatory T cells or selectively inhibit inflammatory T cells and the second agent can reduce an inflammatory response in a tissue of a patient to whom the composition is administered. The second agent can reduce the expression or activity of a pro-inflammatory cytokine, promote the expression or activity of an anti-inflammatory cytokine, or both. | 01-27-2011 |
Jeffrey Flier, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20140147441 | COMPOSITIONS CONTAINING ALPHA-1-ANTITRYPSIN AND METHODS FOR USE - Methods and compositions for treating patients (e.g., patients who are insulin resistant, patients who have diabetes, or are at risk for developing diabetes) are disclosed herein. The methods can include administration of an α1 antitrypsin (AAT) polypeptide or an agent, such as a nucleic acid molecule or organic compound, that promotes the expression or activity of α1-antitrypsin. | 05-29-2014 |